Scientists find class of drugs against gram-negative bacteria

02/18/2010 | Yahoo!

Swiss researchers discovered a class of antibiotics that targets Pseudomonas aeruginosa and other forms of drug-resistant, gram-negative bacteria by inhibiting a protein essential for developing the bacteria's outer cell membrane. Swiss biotech firm Polyphor is in discussions with drugmakers as it seeks to license POL7080, its lead drug candidate against Pseudomonas aeruginosa, said Michael Altorfer, the company's chief financial officer.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC